Vivo Bio Tech (BOM:511509) COGS-to-Revenue : 0.09 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Vivo Bio Tech COGS-to-Revenue?

Vivo Bio Tech's Cost of Goods Sold for the three months ended in Mar. 2024 was ₹10.1 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹117.6 Mil.

Vivo Bio Tech's COGS to Revenue for the three months ended in Mar. 2024 was 0.09.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Vivo Bio Tech's Gross Margin % for the three months ended in Mar. 2024 was 91.38%.

Vivo Bio Tech COGS-to-Revenue Historical Data

The historical data trend for Vivo Bio Tech's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivo Bio Tech COGS-to-Revenue Chart

Vivo Bio Tech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

Get a 7-Day Free Trial

0.15

0.14

0.22

0.13

0.08

Vivo Bio Tech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.09	0.15	0.01	0.08	0.09

Vivo Bio Tech COGS-to-Revenue Calculation

Vivo Bio Tech's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	38.497	/	454.512
	=	0.08

Vivo Bio Tech's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	10.136	/	117.583
	=	0.09

Vivo Bio Tech (BOM:511509) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Vivo Bio Tech's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	10.136 / 117.583
	=	91.38 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Vivo Bio Tech COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Vivo Bio Tech's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivo Bio Tech (BOM:511509) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivo Bio Tech Ltd (BOM:511509) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 8-2-672/ 5 and 6, Road Number 1, 3rd Floor, Ilyas Mohammed Khan Estate, Banjara hills, Hyderabad, TG, IND, 500034

Website

http://www.vivobio.com

Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.

Vivo Bio Tech (BOM:511509) Headlines

No Headlines